Induction of Anti-Tumor Immune Responses by Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in a Murine Model of a Human Neuroendocrine Tumor
Wu, Y.; Pfeifer, A.K.; Myschetzky, R.; Garbyal, R.S.; Rasmussen, P.; Knigge, U.; Bzorek, M.; Kristensen, M.H.; Kjaer, A. Induction of Anti-Tumor Immune Responses by Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in a Murine Model of a Human Neuroendocrine Tumor. Diagnostics 2013, 3, 344-355. https://doi.org/10.3390/diagnostics3040344
Wu Y, Pfeifer AK, Myschetzky R, Garbyal RS, Rasmussen P, Knigge U, Bzorek M, Kristensen MH, Kjaer A. Induction of Anti-Tumor Immune Responses by Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in a Murine Model of a Human Neuroendocrine Tumor. Diagnostics. 2013; 3(4):344-355. https://doi.org/10.3390/diagnostics3040344
Chicago/Turabian StyleWu, Yin, Andreas K. Pfeifer, Rebecca Myschetzky, Rajendra S. Garbyal, Palle Rasmussen, Ulrich Knigge, Michael Bzorek, Michael H. Kristensen, and Andreas Kjaer. 2013. "Induction of Anti-Tumor Immune Responses by Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in a Murine Model of a Human Neuroendocrine Tumor" Diagnostics 3, no. 4: 344-355. https://doi.org/10.3390/diagnostics3040344


